Skip to main content
. 2014 Nov 20;78(6):1315–1333. doi: 10.1111/bcp.12418

Table 2.

Treatment-emergent adverse events in healthy subjects (reported for more than subject)

Preferred term AMG 181 n = 50 n (%) Placebo n = 18 n (%)
Any adverse event 30 (60) 9 (50)
Upper respiratory tract infection 15 (30) 1 (6)
Headache 8 (16) 1 (6)
Oropharyngeal pain 3 (6) 1 (6)
Diarrhoea 1 (2) 2 (11)
Nausea 2 (4) 1 (6)
Dizziness 2 (4) 0 (0)
Abdominal pain 0 (0) 2 (11)
Fatigue 1 (2) 1 (6)
Syncope 1 (2) 1 (6)
Viral infection 1 (2) 1 (6)